StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Nice!

<< Previous

Bullboard Posts

Next >>

Comment by Skrit37on Aug 18, 2022 6:21pm

128 Views

Post# 34906089

RE:RE:RE:Nice!

I hope your right that somehow 177k is all he needs......that would be fantastic!.... I see allot more foreshadowing in there, as far as where future monies will be comming from.. Hopefully the reasons for this is true, as stated in the PR

LithLover wrote: Weren't the bashers trying to say a PP of 20-30 million shares was coming. $177,000 thats all he needs. Nice indeed.

The toxic fiancers and shorters are going to be nervous realizing the company doesn't need much more financing with the growth and cash flow coming in.

Skrit37 wrote: That's definitely the positive way to look at it. Lol